Javascript must be enabled to continue!
Calculating Pharmacokinetic Areas
View through CrossRef
Abstract
Although it is recognized that pharmacokinetic processes follow exponential processes, area under the curve (AUC ) estimations are frequently carried out using linear trapezoidal methods. This is justified based on the fact that most human studies are carried out following oral dosing, and it is believed that a logarithmic trapezoidal method will markedly underpredict the areas for increasing drug concentrations. Here we show that increasing concentrations can be estimated more accurately using a new simple logarithmic method for increasing concentrations. Further, no previous discussion of linear versus logarithmic calculation has been published for area under the moment curve (AUMC ) calculations. Thus, the derivation of a new methodology for calculating area values for logarithmic processes exhibiting increasing values of concentrations and moments is shown. Use of the methodology is presented and compared with the presently utilized linear approach. Pharmacokinetic absorption and elimination processes are primarily assumed to follow an exponential process, so that measurements of concentrations over time exhibit exponential versus linear relationships with time. Therefore, calculations of AUC should be more accurate using logarithmic methods than with linear methods. It is recognized that for decreasing concentrations with time, more accurate calculations of AUC will be estimated using the logarithmic trapezoidal rather than the linear trapezoidal rule. However, it was believed that logarithmic AUC calculations would be more inaccurate for increasing concentrations and moment values. Therefore, there is no generally recommended rule as to how AUCs should be estimated. We show here that a simple logarithmic methodology can be utilized for all increasing values except to the first measurement after time zero. It appears that for concentration-time curves, AUC will be best estimated using logarithmic methods for both increasing and decreasing concentrations. However, it appears that for well-designed sampling schedules, the increased accuracy of using logarithmic trapezoidal methods versus using linear trapezoidal methods is not sufficient to give significant errors in clearance calculations. In contrast, here we show that using linear area calculations for AUMC is probably more accurate than using any combination of linear and logarithmic methods.
Title: Calculating Pharmacokinetic Areas
Description:
Abstract
Although it is recognized that pharmacokinetic processes follow exponential processes, area under the curve (AUC ) estimations are frequently carried out using linear trapezoidal methods.
This is justified based on the fact that most human studies are carried out following oral dosing, and it is believed that a logarithmic trapezoidal method will markedly underpredict the areas for increasing drug concentrations.
Here we show that increasing concentrations can be estimated more accurately using a new simple logarithmic method for increasing concentrations.
Further, no previous discussion of linear versus logarithmic calculation has been published for area under the moment curve (AUMC ) calculations.
Thus, the derivation of a new methodology for calculating area values for logarithmic processes exhibiting increasing values of concentrations and moments is shown.
Use of the methodology is presented and compared with the presently utilized linear approach.
Pharmacokinetic absorption and elimination processes are primarily assumed to follow an exponential process, so that measurements of concentrations over time exhibit exponential versus linear relationships with time.
Therefore, calculations of AUC should be more accurate using logarithmic methods than with linear methods.
It is recognized that for decreasing concentrations with time, more accurate calculations of AUC will be estimated using the logarithmic trapezoidal rather than the linear trapezoidal rule.
However, it was believed that logarithmic AUC calculations would be more inaccurate for increasing concentrations and moment values.
Therefore, there is no generally recommended rule as to how AUCs should be estimated.
We show here that a simple logarithmic methodology can be utilized for all increasing values except to the first measurement after time zero.
It appears that for concentration-time curves, AUC will be best estimated using logarithmic methods for both increasing and decreasing concentrations.
However, it appears that for well-designed sampling schedules, the increased accuracy of using logarithmic trapezoidal methods versus using linear trapezoidal methods is not sufficient to give significant errors in clearance calculations.
In contrast, here we show that using linear area calculations for AUMC is probably more accurate than using any combination of linear and logarithmic methods.
Related Results
Target site bioanalysis and pharmacokinetics of antileishmanial drugs
Target site bioanalysis and pharmacokinetics of antileishmanial drugs
This thesis focuses on bioanalytical method development and validation of
antileishmanial drugs amphotericin B, miltefosine, and paromomycin in human
plasma and human skin tissue f...
A freely accessible, adaptable hollow-fiber setup to reproduce first-order absorption: illustration with linezolid cerebrospinal fluid pharmacokinetic data
A freely accessible, adaptable hollow-fiber setup to reproduce first-order absorption: illustration with linezolid cerebrospinal fluid pharmacokinetic data
Abstract
The main objective of this study was to validate an algorithm and experimental setup to simulate first-order absorption pharmacokinetic ...
In Silico Prediction of Toxicological and Pharmacokinetic Characteristics of Medicinal Compounds
In Silico Prediction of Toxicological and Pharmacokinetic Characteristics of Medicinal Compounds
Scientific relevance. Studies of the toxicological and pharmacokinetic properties of medicinal compounds are a crucial stage of preclinical research; unsatisfactory results may inv...
A population pharmacokinetic model for posaconazole intravenous solution and oral powder for suspension formulations in pediatric patients with neutropenia
A population pharmacokinetic model for posaconazole intravenous solution and oral powder for suspension formulations in pediatric patients with neutropenia
ABSTRACT
The objective of this study was to support posaconazole dose regimens in pediatric patients aged ≥2 years, using a population pharmacok...
Evaluating the pharmacokinetic parameters of a single dose of oral disintegrating tablets in elderly patients with hypertension and hyperlipidemia
Evaluating the pharmacokinetic parameters of a single dose of oral disintegrating tablets in elderly patients with hypertension and hyperlipidemia
Cardiovascular diseases (CVDs) are the leading cause of death worldwide, particularly in underprivileged areas such as Pakistan. Hypertension and hyperlipidemia are major risk fact...
Monte Carlo Simulation of an Ethanol Pharmacokinetic Model
Monte Carlo Simulation of an Ethanol Pharmacokinetic Model
Background One challenge of using even relatively simple pharmacokinetic models is valuation of model parameters. Unknown model parameter values can be determined by fitting the mo...
Population Pharmacokinetics of Clindamycin Hydrochloride Capsules in Chinese health subjects
Population Pharmacokinetics of Clindamycin Hydrochloride Capsules in Chinese health subjects
Aim: The aim of the research is to establish a population
pharmacokinetic (PPK) model of Clindamycin hydrochloride capsules in
Chinese health subjects and investigate the factors a...
Physiologically-based pharmacokinetic modeling for single and multiple dosing regimens of ceftriaxone in healthy and chronic kidney disease populations: a tool for model-informed precision dosing
Physiologically-based pharmacokinetic modeling for single and multiple dosing regimens of ceftriaxone in healthy and chronic kidney disease populations: a tool for model-informed precision dosing
Introduction: Ceftriaxone is one of commonly prescribed beta-lactam antibiotics with several label and off-label clinical indications. A high fraction of administered dose of ceftr...

